Efigalo 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

efigalo 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod

Fingolimod Mylan Unia Europejska - słoweński - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod hidroklorid - multiplo sklerozo, recidivno-nakazila - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 in 5. 1)orpatients s hitro razvijajočimi se hudo recidivno nakazila multiplo sklerozo, opredeljeno z 2 ali več onemogočanje zagonov v enem letu, in z 1 ali več gadolinium krepitev poškodbe na možganih, mri ali znatno povečanje t2 lezije obremenitvi, kot je v primerjavi s predhodnim zadnjih mri.

Efigalo 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

efigalo 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod

Fingolimod Pharmascience 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fingolimod pharmascience 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod

Fingolimod Teva 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fingolimod teva 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod

Fingolimod Teva 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fingolimod teva 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod

Fingolimod Mylan Unia Europejska - słoweński - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod hidroklorid - multiplo sklerozo, recidivno-nakazila - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 in 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Fingolimod STADA 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fingolimod stada 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 tableta - fingolimod

Fingolimod Teva 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fingolimod teva 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod

Inzolfi 0,5 mg trde kapsule Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inzolfi 0,5 mg trde kapsule

fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod